Cusp-overlap technique to reduce permanent pacemaker implantation rate after transcatheter aortic valve implantation
Abstract Background Persistent conduction disturbances requiring permanent pacemaker (PPM) implantation are one of the most common complications after Transcatheter Aortic Valve Implantation (TAVI). Cusp-Overlap Technique (COT) is a novel approach for self-expandable valve implantation to minimize the rate of procedural complications, mainly PPM implantation. Purpose To determine if the COT during TAVI with self-expandable valves leads to a reduction of PPM implantation rate in the real-world setting. Methods A retrospective analysis of consecutive patients undergoing TAVI between January 2020 and November 2023 in one high-volume tertiary care center in Portugal was conducted. Two groups were defined, the COT group and the control group based on the fluoroscopic approach. A baseline comparison between the 2 groups was made using independent-samples t-test and chi-square analysis to determine if there was a difference between the prevalence of known risk factors for PPM implantation after TAVI. Afterwards, chi-square analysis was used to determine if COT led to a reduction in the PPM implantation rate. Results Of the 539 completed procedures in this timeframe, 289 were excluded due to previous pacemaker implantation, use of a valve not amenable to COT or valve-in-valve implantation. COT was used in 57.6% of eligible cases. Baseline comparison did not show a significant difference in the prevalence of several known risk factors for PPM implantation, including complete right bundle branch block, atrio-ventricular block, calcium score, aortic ring dimensions and pre/post-dilation. PPM implantation after TAVI was required in 31.6% of cases. In the COT group the PPM implantation rate was 22.9% and in the control group 43.4%. Chi-square analysis showed a very statistically significant difference between the 2 analyzed groups (p-value = 0.001). Conclusion PPM implantation remains a frequent complication of TAVI. However, this study showed that the utilization of COT leads to a reduction of the PPM implantation rate.
Authors
- A Grazina (ORCID: https://orcid.org/0000-0003-0748-0046)
- Francisco Albuquerque (ORCID: https://orcid.org/0000-0002-6317-4847)
- Rúben Ramos (ORCID: https://orcid.org/0000-0003-0736-3878)
- T Mendonca (ORCID: https://orcid.org/0000-0002-4223-9162)
- Sónia Rodrigues (ORCID: https://orcid.org/0000-0002-9431-1402)
- B Lacerda Teixeira (ORCID: https://orcid.org/0000-0003-0527-2681)
- Duarte Cacela (ORCID: https://orcid.org/0009-0007-6597-5633)
- António José Fiarresga (ORCID: https://orcid.org/0000-0003-1912-4989)
- R Carvalheiro (ORCID: https://orcid.org/0009-0006-6342-1146)
- Filipa Ferreira (ORCID: https://orcid.org/0000-0003-2555-4176)
- M.M. Figueiredo (ORCID: https://orcid.org/0000-0002-2868-8332)
Institutions
- Unidade Local de Saúde de São José (PT)
Publication Details
- Journal
- European Heart Journal
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1093/eurheartj/ehae666.1848
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00